All Posts Tagged With: "ZOLL"
(MDT) MedTech Industry Stock Outlook – March 2012 – Zacks Analyst Interviews
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure...
(MDT) MedTech Industry Stock Outlook – March 2012 – Industry Outlook
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure...
(ZOLL) ZOLL Medical Corporation – Bull of the Day
We retain our Outperform recommendation on ZOLL Medical Corp. (ZOLL) following its forecast-topping first quarter results. Revenues and earnings for the quarter beat the Zacks Consensus Estimates, driven...
(STJ) New Year Bets from MedTech
Picking the right stock is never easy, especially in a difficult and volatile market. There are thousands of stocks to choose from and many investors eventually end up boiling the ocean.
The U.S. economy continues to be cramped by a spate of headwinds including a still...
(ZOLL) ZOLL Medical’s AutoPulse Tapped by WSPR Szczecin
Resuscitation devices maker ZOLL Medical (ZOLL) said that its new AutoPulse Plus cardiac support pumps has been bought by WSPR Szczecin, the biggest emergency service operator in Poland. The Polish entity...
(ZOLL) ZOLL Medical Corporation – Bull of the Day
We upgrade our recommendation on ZOLL Medical Corp. (ZOLL) to Outperform following its forecast-topping fourth quarter results. Revenues and earnings for the quarter outperformed the Zacks Consensus Estimates,...
(MDT) Medical Technology Industry Stock Outlook – November 2011 – Industry Outlook
The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures,...
(MDT) Medical Devices Stock Outlook – Sept. 2011 – Industry Outlook
June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected...
(MDT) Medical Devices Stock Outlook – June 2011 – Industry Outlook
A host of macro headwinds (including price and procedure volume pressure) which hit the MedTech industry last year continued to haunt the sector during the March quarter and encumber growth. Although a number of these issues are expected to linger through the remainder of...
(ZOLL) ZOLL Analyst Maintains Shares at Neutral
We maintain our Neutral recommendation on resuscitation devices maker ZOLL Medical (ZOLL). Revenues and earnings for second-quarter fiscal 2011 beat the Zacks Consensus Estimates driven by...
(ZOLL) ZOLL Medical’s Propaq Cleared in Canada
Resuscitation devices maker ZOLL Medical (ZOLL) has secured approval from Health Canada to market its Propaq MD monitor/ defibrillator and Propaq M monitor to military customers and air medical operations...
(ZOLL) ZOLL Medical Ships New AED Plus
Massachusetts-based medical devices maker ZOLL Medical (ZOLL) recently began shipping a new version of its AED Plus devices for treating sudden cardiac arrest (“SCA”). This new version is fully compliant...
(MDT) Medical Devices Industry Outlook – April 2011 – Industry Outlook
Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory...
(ZOLL) ZOLL Medical’s LifeVest Defibrillator Hits Milestone
Resuscitation devices maker ZOLL Medical’s (ZOLL) popular LifeVest wearable defibrillator has reached another key milestone as it has been reportedly prescribed to over 35,000...
(ZOLL) ZOLL’s Medical Earnings Per Share Beats Expectations – Profit Doubles
Resuscitation devices and software company ZOLL Medical (ZOLL) reported fourth-quarter fiscal 2010 (ended October 3) earnings of 33 cents, beating the Zacks Consensus Estimate of 31 cents and exceeding the...
(MDT) Medical Devices Industry Outlook December 2010 – Industry Outlook
Industry Dynamics
The global medical devices industry is fairly large, intensely competitive and highly innovative with 2009 worldwide sales in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into...
(HUM) June 2010 – Industry Outlook – Health Care Stock Review
The health care sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors in this sector should be mindful...
(ZOLL) ZOLL Medical Corporation Analyst Upgrades to Outperform
Recently, we upgraded ZOLL Medical Corporation (ZOLL) to Outperform from Neutral with a price target of $38 primarily driven by the better-than-expected second quarter fiscal 2010 results as released on April...
(ZOLL) ZOLL Medical Earnings Scorecard
Following the release of second quarter fiscal 2010 (ended April 4, 2010) results on April 29, 2010, majority of the analysts covering ZOLL Medical Corporation (ZOLL) have made upward revisions to their 2010...
(ZOLL) ZOLL Medical Corporation – Bull of the Day
ZOLL Medical Corporation’s (ZOLL) second quarter fiscal 2010 earnings of $0.17 per share surpassed the Zacks Consensus Estimate by $0.04. The better-than-expected results were driven by the strong showing...
(ZOLL) ZOLL Medical Corporation Report Tops Consensus
ZOLL Medical Corp.’s (ZOLL) second quarter fiscal 2010 (ended Apr 4, 2010) earnings of 17 cents per share surpassed the Zacks Consensus Estimate by 4 cents. The company earned 8 cents per share in the year-ago...
(WLP) Health Care Outlook & Stock Review – Industry Outlook
OVERVIEW
The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors...
(ZOLL) ZOLL Medical Corporation Analysts Downgrade to Neutral
We have downgraded ZOLL Medical Corporation (ZOLL) to Neutral from Outperform with a price target of $29.50. Even though we are pleased with the company’s significant international presence — which...
(ZOLL) ZOLL Medical Corporation – Fourth-Quarter Results Beat by 100%
ZOLL Medical Corp. (ZOLL) just hit a new 52-week high on continued momentum from the company’s better than expected Q4 results from early November.
Company Description
(ZOLL) ZOLL Medical Corporation Earns FDA Clearance
Recently, ZOLL Medical Corporation (ZOLL) announced that the U.S. Food and Drug Administration (FDA) approved the marketing of its E series defibrillators equipped with carbon monoxide (CO) monitoring. The...
(UNH) Healthcare Stock Review – December 2009 – Industry Outlook
OVERVIEW
The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors...
(ZOLL) ZOLL Medical Corporation – Bull of the Day
ZOLL Medical Corporation (ZOLL) reported fourth quarter earnings of 16 cents per share, beating the Zacks Consensus Estimate of 8 cents. The company earned 41 cents per share in the year-ago quarter.
For...
(ZOLL) ZOLL Medical Corporation Upgraded to Outperform
We are upgrading ZOLL Medical Corp. (ZOLL) to Outperform from Neutral. We are pleased with the company’s wide range of products and significant international presence. The company has made multiple acquisitions...
(ZOLL) ZOLL Medical Beats Expectations in Recent Quarter
ZOLL Medical Corp. (ZOLL) reported fourth-quarter earnings of 16 cents per share, which beat the Zacks Consensus Estimate of 8 cents. The company earned 41 cents in the year-ago quarter. The lower profit...
(ZOLL) ZOLL’s New Wearable Defibrillator Approved
ZOLL Medical (ZOLL) obtained clearance from the U.S. Food and Drug Administration (FDA) for its new model of the LifeVest wearable defibrillator. The physicians advise LifeVest for their patients, who run the risk of sudden cardiac arrest. LifeVest enables...